De-risk your product development with reliable preclinical research

Get the clarity you need to move forward with confidence.

Make informed decision-making throughout your product’s non-clinical development. Our suite of preclinical studies includes: 

  • Pharmacodynamics
  • Safety pharmacology
  • Biocompatibility studies
  • Metabolism and pharmacokinetics
  • Toxicity

We are dedicated to delivering non-GLP studies for a wide range of novel candidates, including:

  • Drugs
  • Advanced Therapies (ATMPs): TEP, CBMP, GTMP
  • Medical Devices
  • Food Supplements

Our preclinical department has the infrastructure and expertise to conduct your In vitro and In vivo studies, leveraging partnerships for animal housing. Our dedicated management system, ISO9001 certified, ensures quality and efficiency throughout the process.

Our scientists hold a rich portfolio of validated disease models to conduct your preclinical study or develop new models tailored to your specific needs. We collaborate closely with you to refine your study protocol and pharmacodynamic data, ensuring your product development is optimized and transitions seamlessly into the clinical phase.

Why Choose Artialis’ Preclinical Services?

Choosing the right partner for your preclinical studies is crucial.

Here is what makes us unique:

Why Choose Artialis’ Preclinical Services?

Choosing the right partner for your preclinical studies is crucial. Here is what makes us unique:

Deep Scientific Expertise

Our team of scientists possesses extensive experience in designing and conducting preclinical studies focused on the mechanisms of aging and age-related conditions.

Flexible Approach

We understand that every research program is unique. We work closely with you to develop a customized study design that meets your specific research objectives and timelines.

Global Capabilities

We leverage a strong network of partners to provide comprehensive support and resources for your preclinical research needs. 

Proven Expertise

Our commitment to scientific excellence is reflected in our 52 peer-reviewed publications. This allows us to offer robust and scientifically sound study designs. 

Transparent Communication

We provide regular progress updates to keep you informed and ensure alignment throughout your study. 

Efficient Project Management

We develop detailed project plans and timelines in collaboration with you to ensure clear expectations and efficient progress.

Our Preclinical services

How we help lay the foundation for Clinical success

In Vivo Test
Systems

In Vitro Test
Systems

Biocompatibility
Studies

Macroscopy & Histology

Mobility & Pain Platform

Post-study
services

Our Preclinical services

How we help lay the foundation for Clinical success

In Vivo Test
Systems

In Vitro Test
Systems

Biocompatibility
Studies

Macroscopy & Histology

Mobility & Pain Platform

Post-study
services

Our FAQs

We offer a wide range of services, including:

  • In vitro studies: Conducted in laboratory settings using primary cells and cell lines to evaluate the mode of action, pharmacodynamics or cytotoxicity effects of a product candidate.
  • In vivo studies: Conducted in animal models (healthy or disease) to assess the pharmacodynamics, safety pharmacology, toxicity, pharmacokinetics or metabolism of a product candidate.
  • Ex vivo studies: Conducted in laboratory settings using tissue biopsies to evaluate the effects of a product candidate on structural or biomolecular changes.
  • Bioanalytical studies: Conducted to measure the concentration of biomarkers in samples collected during in vitro (culture supernatants) or in vivo studies (serum, plasma, urine or synovial fluid).
  • Regulatory support: We can also provide assistance with regulatory submissions, such as Investigational New Drug (IND) applications for your product candidate.

There are numerous reasons to choose Artialis as a preclinical CRO, including:

  • Expertise: Artialis has a dedicated team of experts with an extensive experience in all aspects of preclinical research from study set-up to data delivery.
  • Resources: Artialis, as a preclinical CRO, has access to the latest facilities, equipment, and technologies.
  • Quality: Artialis is committed to providing high-quality data that meets the highest regulatory standards.
  • Efficiency: Artialis can help you to streamline your drug development process, saving both time and money

The duration of a preclinical study will vary depending on the complexity of the study and the specific objectives. However, most in vivo preclinical studies can be completed within 6 to 12 months while in vitro studies are performed within 2 and 6 months.

Depending on the complexity of the study and the availability of resources, most preclinical studies can be initiated within 4 to 8 weeks.

We are committed to protecting the confidentiality of our clients’ information. We have in place strict data security policies and procedures, included in our extensive quality management system, and we only share information with authorized personnel.

We would be happy to provide you with more information about our successful projects. Please contact us for more details.

Leverage our preclinical expertise in healthy aging

Submit a proposal request today and discuss your preclinical study needs with our experts.